BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 38233164)

  • 1. Precisely Activating cGAS-STING Pathway with a Novel Peptide-Based Nanoagonist to Potentiate Immune Checkpoint Blockade Cancer Immunotherapy.
    Xing Y; Peng A; Yang J; Cheng Z; Yue Y; Liu F; Li F; Liu Y; Liu Q
    Adv Sci (Weinh); 2024 Apr; 11(15):e2309583. PubMed ID: 38233164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the cGAS-STING pathway combined with CRISPR-Cas9 gene editing triggering long-term immunotherapy.
    Lu Q; Chen R; Du S; Chen C; Pan Y; Luan X; Yang J; Zeng F; He B; Han X; Song Y
    Biomaterials; 2022 Dec; 291():121871. PubMed ID: 36323073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy.
    Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J
    Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS-STING pathway to mediate GBM immune escape.
    Zhu W; Rao J; Zhang LH; Xue KM; Li L; Li JJ; Chen QZ; Fu R
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death.
    Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z
    Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
    Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
    Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS-STING pathway.
    Guo Y; Shen R; Wang F; Wang Y; Xia P; Wu R; Liu X; Ye W; Tian Y; Wang D
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6315-6328. PubMed ID: 36745223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation.
    Xiang W; Lv H; Xing F; Sun X; Ma Y; Wu L; Lv G; Zong Q; Wang L; Wu Z; Feng Q; Yang W; Wang H
    Sci Adv; 2023 Dec; 9(49):eadi2465. PubMed ID: 38055816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of IFN-gamma with STING agonist and PD-1 immune checkpoint blockade: a potential immunotherapy for gastric cancer.
    Hosseinzadeh S; Imani M; Pourfarzi F; Jafari N; AbedianKenari S; Safarzadeh E
    Med Oncol; 2024 Apr; 41(5):110. PubMed ID: 38592576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy.
    Cao L; Tian H; Fang M; Xu Z; Tang D; Chen J; Yin J; Xiao H; Shang K; Han H; Li X
    Biomaterials; 2022 Nov; 290():121856. PubMed ID: 36306685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
    Hu M; Zhou M; Bao X; Pan D; Jiao M; Liu X; Li F; Li CY
    J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33290271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer.
    Meng J; Peng J; Feng J; Maurer J; Li X; Li Y; Yao S; Chu R; Pan X; Li J; Zhang T; Liu L; Zhang Q; Yuan Z; Bu H; Song K; Kong B
    J Transl Med; 2021 Oct; 19(1):415. PubMed ID: 34620163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer.
    Zhou L; Xu Q; Huang L; Jin J; Zuo X; Zhang Q; Ye L; Zhu S; Zhan P; Ren J; Lv T; Song Y
    Cancer Lett; 2021 Mar; 500():163-171. PubMed ID: 33278498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonodynamic amplification of cGAS-STING activation by cobalt-based nanoagonist against bone and metastatic tumor.
    Lei J; Zhang W; Ma L; He Y; Liang H; Zhang X; Li G; Feng X; Tan L; Yang C
    Biomaterials; 2023 Nov; 302():122295. PubMed ID: 37666101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin/SN38 co-loaded liposomes amplified ICB therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cGAS-STING pathway.
    Yang Y; Qi J; Hu J; Zhou Y; Zheng J; Deng W; Inam M; Guo J; Xie Y; Li Y; Xu C; Deng W; Chen W
    Cancer Lett; 2024 Apr; 588():216765. PubMed ID: 38408604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.